Black Diamond Therapeutics schedules investor webcast on silevertinib trial
Tweet Send to a Friend
Black Diamond Therapeutics Inc. (NASDAQ: BDTX) will host an investor webcast on May 21, 2026, at 5:30 p.m. ET to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


